Effect of sustained endotoxemia on α1-adrenergic responsiveness in parenterally fed rats

Pharmacotherapy

Volumn 18, Issue 1, 1998, Pages 170-174

  Dickerson, Roland N ^a   Lima, John J ^a   Kuhl, David A ^a   Brown, Rex O ^a   Hak, Lawrence J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ENDOTOXIN; HYPERTENSIVE AGENT; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CRITICAL ILLNESS; DOSE RESPONSE; DRUG HALF LIFE; ENDOTOXEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARENTERAL NUTRITION; RAT; RECEPTOR DOWN REGULATION; SMOOTH MUSCLE CONTRACTION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; BLOOD PRESSURE; ENDOTOXEMIA; ESCHERICHIA COLI; MALE; PARENTERAL NUTRITION; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; VASOCONSTRICTOR AGENTS;

EID: 0031984745     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lherm T, Troche G, Rossignol M, Bordes P, Zazzo JF. Renal effects of low dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 1996;22:213-19.
2. Maze M, Spiss CK, Tsujimoto G, Hoffman BB. Epinephrine infusion induces hyporesponsiveness of vascular smooth muscle. Life Sci 1985;37:1571-8.
3. Lurie KG, Tsujimoto G, Hoffman BB. Desensitization of alpha-1 adrenergic receptor-mediated vascular smooth muscle contraction. J Pharm Exp Ther 1985;234:147-52.
4. Rosenbaum JS, Zera P, Umans VA, Ginsburg R, Hoffman BB. Desensitization of aortic smooth muscle contraction in rats harboring pheochromocytoma. J Pharm Exp Ther 1986;238: 396-400.
5. Colucci WS, Alexander RW. Norepinephrine-induced alteration in the coupling of alpha-1 adrenergic receptor occupancy to calcium efflux in rabbit aortic smooth muscle cells. Proc Natl Acad Sci 1986;83:1743-6.
6. Carrier O, Wedell EK, Barron KW. Specific alpha adrenergic receptor desensitization in vascular smooth muscle. Blood Vessels 1978;15:247-58.
7. Auclair MC, Carli A, Lechat P. Decrease of the hypertensive responses to phenylephrine in the rat submitted to a sublethal dose of E. coli endotoxin. J Pharmacol 1982;13:341-51.
8. Seaman KL, Greenway CV. Loss of hepatic venous responsiveness after endotoxin in anesthetized cats. Am J Physiol 1984;246:H658-63.
9. Wakabayashi I, Hatake K, Kakishita E, Nagai K. Diminution of contractile response of the aorta from endotoxin-injected rats. Eur J Pharmacol 1987;141:117-22.
10. Wakabayashi I, Kakashita E, Hatake K, Hishida S, Nagai K. Effect of phorbol ester on contractile response of aorta from endotoxic rats. Biochem Biophys Res Commun 1988;150:1115-21.
11. Wakabayashi I, Hatake K, Kakishita E, Hishida S, Nagai K. Desensitization of alpha-1 adrenergic receptor mediated smooth muscle contraction in aorta from endotoxemic rats. Life Sci 1989;45:509-15.
12. Parratt JR. Myocardial and circulatory effects of E, coli endotoxin; modification of response to catecholamines. Br J Pharmacol 1973;47:12-25.
13. Bone R, Grodzin C, Balk R. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 1997;112:235-43.
14. Dickerson RN, Manzo CB, Charland SL, Settle RG, Kuhl DA, Rajter JJ. The effect of insulin-like growth factor-1 on protein metabolism and hepatic response to endotoxemia in parenterally fed rats. J Surg Res 1995;58:260-6.
15. Dickerson RN, Brown RO, Mouser JF, et al. Dose-dependent effect of octreotide on nitrogen retention and glucose homeostasis in response to endotoxemia in parenterally fed rats. J Am Coll Nutr 1997;16:74-80.
16. Manzo CB, Dickerson RN, Settle RG, Rajter JJ. Insulin-like growth factor 1 and endotoxin-mediated kidney dysfunction in critically ill, parenterally fed rats. Nutrition 1993;9:528-31.
17. Council NR. Nutrient requirements of laboratory animals, 3rd ed. Washington, DC: National Academy of Sciences, 1978.
18. Holford NHG, Sheiner LB. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981;6: 429-53.
19. Metzler CM, Elfring GK, McEwen AJ. A package of computer programs for pharmacokinetic modeling. Biometrics 1974;30:562-3.
20. Akaike H. A Bayesian analysis of the minimum AIC procedure. Ann Inst Stat Math A 1978;30:9-14.
21. Gray GA, Schott C, Julou-Schaefer G, Fleming I, Parratt JR, Stoclet JC. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 1991;103:1218-24.
22. Pastor CM, Billiar TR. Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats. Am J Physiol 1995;268:G177-82.
23. Wang P, Ba ZF, Chaudry IH. Nitric oxide: to block or enhance its production during sepsis? Arch Surg 1994;129:1137-43.
24. Garcia-Barreno P, Suarez A. Modification of catecholamine and prostaglandin tissue levels in E. coli endotoxin-treated rats. J Surg Res 1988;44:178-84.
25. Jones SB, Romano FD. Plasma catecholamines in the conscious rat during endotoxicosis. Circ Shock 1984;14:189-201.
26. Jepson MM, Pell JM, Bates CP, Millward D. The effects of endotoxemia on protein metabolism in skeletal muscle and liver of fed and fasted rats. Biochem J 1986;235:329-36.
27. Deitch EA, Ma WJ, Ma L, Berg R, Specian RD. Endotoxin-induced bacterial translocation: a study of mechanisms. Surgery 1989;106:292-300.
28. Postel J, Schloerb PR, Furtado D. Pathophysiologic alterations during bacterial infusions for the study of bacteremic shock. Surg Gynecol Obstet 1975;141:683-92.
29. Martinez GLA, Quintiliani R, Tilton R. Clinical experience on the detection of endotoxemia with the limulus test. J Infect Dis 1973;127:102.
30. Smith RB, Kroboth PD. Alprazolam: development of a pharmacodynamic tolerance model. In: Kroboth PD, Smith RM, Juhl RP, eds. Pharmacokinetics and pharmacodynamics: current problems, potential solutions. Cincinnati: Harvey Whitney Books, 1988:75-89.
31. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 1990;49:186-96.
32. Dahn MS, Lange MP, Jacobs LA. Insulin-like growth factor 1 production is inhibited in human sepsis. Arch Surg 1988;123:1409-14.
33. Wichterman KA, Baue AE, Chaudry I. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 1980;29:189-201.